Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: An audit of practice

International Journal of Surgery

Volumn 5, Issue 2, 2007, Pages 114-119

  Balibrea, J L ^a   Altimiras, J ^b   Larruzea, I ^c   Gomez Outes A ^d   Martinez Gonzalez J ^d   Rocha, E ^e  

^a SCHOOL OF MEDICINE   (Spain)

^b Corporació Sanitaria Parc Taulí ^*  (Spain)

^c Hospital de San Eloy   (Spain)

^d AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Bemiparin; Cancer surgery; Low molecular weight heparin; Venous thromboembolism

Indexed keywords

BEMIPARIN;

ARTICLE; CANCER PATIENT; HUMAN; MEDICAL AUDIT; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; SURGICAL PATIENT; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 34247367703     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2006.07.005     Document Type: Article

References (23)

1. Nurmohamed M.T., Rosendaal F.R., Buller H.R., Dekker E., Hommes D.W., Vandenbroucke J.P., et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 340 (1992) 152-156
2. Mismetti P., Laporte S., Darmon J.Y., Buchmuller A., and Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88 (2001) 913-930
3. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 126 Suppl. 3 (2004) 338S-400S
4. Nicolaides A.N., Breddin H.K., Fareed J., Goldhaber S., Haas S., Hull R., et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 20 (2001) 1-37
5. Prandoni P., Piccioli A., and Girolami A. Cancer and venous thromboembolism: an overview. Haematologica 84 (1999) 437-445
6. Prandoni P., Lensing A.W.A., Piccioli A., Bernardi E., Simioni P., Girolami B., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100 (2002) 3484-3488
7. Marassi A., Balzano G., Mari G., D'Angelo S.V., Della Valle P., Di Carlo V., et al. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216). Int Surg 78 (1993) 166-170
8. Ho Y.H., Seow-Choen F., Leong A., Eu K.W., Nyam D., and Teoh M.K. Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients. Dis Colon Rectum 42 (1999) 196-203
9. Ockelford P.A., Patterson J., and Johns A.S. A double-blind randomized placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin). Thromb Haemost 62 (1989) 1046-1049
10. Pezzuoli G., Neri Serneri G.G., Settembrini P., Coggi G., Olivari N., Buzzetti G., et al. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin CY 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). Int Surg 74 (1989) 205-210
11. Planès A. Review on bemiparin sodium - a new second generation low-molecular-weight heparin - and its applications in venous thromboembolism. Expert Opin Pharmacother 4 (2003) 1551-1561
12. Chapman T.M., and Goa K.L. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis. Drugs 63 (2003) 2357-2377
13. Navarro-Quilis A., Castellet E., Rocha E., Paz-Jiménez J., and Planès A. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty. A randomized double-blind clinical trial. J Thromb Haemost 1 (2003) 425-432
14. General Council of Official Associations of Pharmacists. Catalogue of pharmaceutical products (2002), General Council of Official Associations of Pharmacists, Madrid
15. Order of 26th December 2001 of the General Section of the National Healthcare Institute, on the revision of the prices that healthcare centres must apply for the services rendered in the cases when the sums must be requested from third parties who are obliged to pay or from users not entitled to healthcare assistance form the National Health System 5 (2001), BOE. http://www.boe.es [accessed 31.10.03]
16. Foral Order 83/2002, of 15th May, by the Healthcare Advisor, pursuant to which the tariffs for services rendered in the Healthcare Sentences of Servicio Navarro de Salud-Osasunbidea are approve 91 (2002), Boletín Oficial de Navarra. http://www.cfnavarra.es [accessed 31.10.03]
17. Kirwan C.C., Nath E., Byrne G.J., and McCollum C.N. Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey. BMJ 327 (2003) 597-598
18. Kakkar V.V., Howes J., Sharma V., and Kadziola Z. A comparative, double-blind, randomized trial of a new-second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism in patients undergoing hip arthroplasty. Thromb Haemost 83 (2000) 523-529
19. Tryba M. European practice guidelines: thromboembolism prophylaxis and regional anesthesia. Reg Anesth Pain Med 23 Suppl. 2 (1998) 178-182
20. Horlocker T.T., Wedel D.J., Benzon H., Brown D.L., Enneking F.K., Heit J.A., et al. Regional anesthesia in the anticoagulated patient: defining the risks. Reg Anesth Pain Med 29 Suppl. 2 (2004) 1-12
21. Raich-Brufau M., Martínez-González J., and Bustos-Molina F. Encuesta nacional sobre la prevención de la enfermedad tromboembólica venosa en cirugía mayor ambulatoria. Cir May Amb 9 (2004) 31-36
22. Raskob G.E., and Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopaedic surgery. Chest 124 (2003) 379S-385S
23. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 312 (2001) 1215-1218